No. S 474
Poisons Act
Poisons Act (Amendment of Schedule) Notification 2002
In exercise of the powers conferred by section 3(2) of the Poisons Act, the Minister for Health hereby makes the following Notification:
Citation and commencement
1.  This Notification may be cited as the Poisons Act (Amendment of Schedule) Notification 2002 and shall come into operation on 16th September 2002.
Amendment of Schedule
2.  The Schedule to the Poisons Act is amended —
(a)by inserting, immediately below the item “Almitrine; its salts”, the following item:
Alosetron; its salts”;
(b)by inserting, immediately below the item “Atorvastatin; its salts”, the following item:
Atosiban; its salts”;
(c)by deleting the item “Bupivacaine; its salts” and substituting the following item:
Bupivacaine; its salts; its isomers; their salts”;
(d)by inserting, immediately below the item “Calabar bean; alkaloids of; their quarternary compounds; their salts”, the following item:
Calcipotriol”;
(e)by inserting, immediately below the item “Carvedilol”, the following item:
Caspofungin; its salts”;
(f)by deleting the item “Cetirizine; its salts” and substituting the following items:
Cetirizine; its salts; its isomers; their salts
Cetrorelix; its salts”;
(g)by inserting, immediately below the item “Clindamycin; its salts; its esters; their salts”, the following item:
Clioquinol”;
(h)by inserting, immediately below the item “Daclizumab”, the following item:
Dalfopristin”;
(i)by inserting, immediately below the item “Debrisoquine; its salts”, the following items:
Deferiprone
Deferoxamine; its salts”;
(j)by inserting, immediately below the item “Doxepin; its salts”, the following item:
Doxofylline; its salts”;
(k)by inserting, immediately below the item “Droperidol”, the following item:
Drosperinone”;
(l)by inserting, immediately below the item “Elaterin”, the following item:
Eletriptan; its salts”;
(m)by inserting, immediately below the item “Etafedrine; its salts”, the following item:
Etanercept”;
(n)by inserting, immediately below the item “Etonitazene; its salts”, the following item:
Etonogestrel”;
(o)by inserting, immediately below the item “Etoposide; its salts”, the following item:
Etoricoxib”;
(p)by inserting, immediately below the item “Feprazone”, the following item:
Fexofenadine; its salts; its esters; their salts”;
(q)by inserting, immediately below the item “Follicle stimulating hormone (FSH)”, the following item:
Fondaparinux; its salts”;
(r)by inserting, immediately below the item “Gadopentetic acid; its salts”, the following item:
Gadoversetamide”;
(s)by inserting, immediately below the item “Ganciclovir; its salts”, the following items:
Ganirelix; its salts
Gatifloxacin; its salts; its isomers; its esters; their salts”;
(t)by inserting, immediately below the item “Gemfibrozil; its salts; its esters and salts of such esters”, the following item:
Gemtuzumab Ozogamicin”;
(u)by inserting, immediately below the item “Ifosfamide”, the following item:
Imatinib; its salts”;
(v)by deleting the item “Insulin” and substituting the following item:
Insulins”;
(w)by inserting, immediately below the item “Itraconazole”, the following item:
Ivermectin”;
(x)by inserting, immediately below the item “Lepirudin”, the following item:
Lercanidipine; its salts”;
(y)by inserting, immediately below the item “Levamphetamine; its salts”, the following item:
Levetiracetam; its salts; its isomers; their salts”;
(z)by inserting, immediately below the item “Levorphanol; its salts; its esters and ethers; their salts”, the following item:
Levosimendan”;
(za)by inserting, immediately below the item “Loperamide; its salts”, the following item:
Lopinavir”;
(zb)by deleting the item “Luteinising hormone” and substituting the following items:
Lumefantrine; its salts; its isomers; their salts
Luteinising hormones”;
(zc)by inserting, immediately below the item “Midazolam; its salts”, the following item:
Midodrine; its salts; its isomers; their salts”;
(zd)by inserting, immediately below the item “Natamycin; its salts; its esters; their salts”, the following item:
Nateglinide”;
(ze)by inserting, immediately below the item “Nealbarbitone”, the following item:
Nebivolol; its salts”;
(zf)by deleting the item “Omeprazole; its salts” and substituting the following item:
Omeprazole; its salts; its isomers; their salts”;
(zg)by inserting, immediately below the item “Orthocaine; its salts”, the following item:
Oseltamivir; its salts”;
(zh)by inserting, immediately below the item “Pargyline; its salts”, the following item:
Paricalcitol”;
(zi)by inserting, immediately below the item “Piperidolate; its salts”, the following item:
Piper methysticum (kava-kava), the active constituents of; kava pyrones (kavalactones); their quarternary compounds; their salts”;
(zj)by deleting the item “Pyrantel; its salts”;
(zk)by inserting, immediately below the item “Quinine; its quarternary compounds, their salts”, the following item:
Quinupristin”;
(zl)by inserting, immediately below the item “Racemorphan; its salts; its esters and ethers; their salts”, the following item:
Radioactive iodine, salts of; when are intended for the treatment of human ailments”;
(zm)by inserting, immediately below the item “Ranitidine; its salts”, the following item:
Rasburicase”;
(zn)by inserting, immediately below the item “Reserpine”, the following item:
Residronic acid; its salts”;
(zo)by inserting, immediately below the item “Sevoflurane”, the following item:
Sibutramine; its salts”;
(zp)by inserting, immediately below the item “Simvastatin”, the following item:
Sirolimus”;
(zq)by inserting, immediately below the item “Streptozocin”, the following item:
Strontium [89Sr], salts of; when are intended for the treatment of human ailments”;
(zr)by inserting, immediately below the item “Teicoplanin”, the following item:
Telithromycin; its salts”;
(zs)by inserting, immediately below the item “Temazepam”, the following items:
Temozolomide
Tenecteplase”;
(zt)by inserting, immediately below the item “Thyroxine; its salts”, the following item:
Tiagabine; its salts; its esters; their salts”;
(zu)by inserting, immediately below the item “Tioconazole”, the following item:
Tiotropium; its salts”;
(zv)by inserting, immediately below the item “Trastuzumab”, the following item:
Travoprost”;
(zw)by deleting the item “Ubidecarenone (Co-enzyme Q10)”;
(zx)by inserting, immediately below the item “Urapidil; its salts”, the following item:
Urea, when contained in preparations intended for treatment of human ailments and containing more than 10% of urea”;
(zy)by inserting, immediately below the item “Veratrum; alkaloids of; its quarternary compounds; their salts”, the following item:
Verteporfin; its salts; its isomers; their salts”; and
(zz)by inserting, immediately below the item “Zipeprol; its salts”, the following items:
Ziprasidone; its salts
Zolendronic acid; its salts”.
Made this 5th day of September 2002.
MOSES LEE
Permanent Secretary,
Ministry of Health,
Singapore.
[CPA (PER): 78:01 Vol. 5; AG/LEG/SL/234/2002/1 Vol. 1]